Recent years have seen a surge in innovative therapies such as immunotherapy, targeted therapy, and CAR-T cell therapy. Immunotherapy drugs like checkpoint inhibitors have shown promise in treating various types of cancer by enabling the immune system to better recognize and attack cancer cells. Targeted therapies aim at specific genetic mutations within cancer cells, offering a more personalized approach. Meanwhile, CAR-T cell therapy involves modifying a patient’s T cells to better attack cancer cells.
